SCHEMBL293023

SCHEMBL293023

O=C(Cc1ccncc1)N1CCNCC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FNTA P49354 4/20 0.57
FNTB P49356 4/20 0.57
SMN1; SMN2 Q16637 2/20 0.46
NPC1 O15118 1/20 0.46
HPGD P15428 1/20 0.46
ADRB2 P07550 1/20 0.46
NCF1 P14598 1/20 0.46
PLD1 Q13393 1/20 0.46
TPSAB1 Q15661 1/20 0.45
TPSD1 Q9BZJ3 1/20 0.45
TPSG1 Q9NRR2 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
KDM4E B2RXH2 3/20 0.45
ALDH1A1 P00352 2/20 0.45
ECE2 P0DPD6 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HSD11B1 P28845 1/20 0.44
GLA P06280 1/20 0.44
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3673014 0.87 SMN1; SMN2 (0.58) SMN1; SMN2NPC1HPGDTPSAB1TPSD1
SCHEMBL8118154 0.84 SMN1; SMN2 (0.65) FNTAFNTBSMN1; SMN2NPC1HPGD
SCHEMBL92506 0.82 L3MBTL1 (0.63) SMN1; SMN2HPGDKDM4EALDH1A1L3MBTL1
SCHEMBL3994894 0.81 MAPT (0.63) FNTAFNTBSMN1; SMN2KDM4EALDH1A1
SCHEMBL3581351 0.81 FNTA (0.62) FNTAFNTBHPGDCYP3A4KDM4E
SCHEMBL29958765 0.81 FNTA (0.62) FNTAFNTBHPGDCYP3A4KDM4E
SCHEMBL8934908 0.81 ME2 (0.57) SMN1; SMN2NPC1HPGDTPSAB1TPSD1
SCHEMBL9090627 0.81 L3MBTL1 (0.61) SMN1; SMN2HPGDKDM4EALDH1A1L3MBTL1
Hydrochloric Acid SCHEMBL20337874 0.81 L3MBTL1 (0.61) SMN1; SMN2HPGDKDM4EALDH1A1L3MBTL1
SCHEMBL3211666 0.79 HSD11B1 (0.55) FNTAFNTBHPGDCYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3124482-A1 QUINOLINE DERIVATIVES AS SMO INHIBITORS GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD (CN) 2017-02-01 EP disclosed
EP-2284169-B1 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of CNS disorders OTSUKA PHARMA CO LTD (JP) 2012-03-14 EP disclosed
EP-1919907-A2 HETEROCYCLIC COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-05-14 EP disclosed
WO-2007026959-A2 DERIVATIVES OF 4-PIPERAZIN-1-YL-4-BENZ0 [B] THIOPHENE SUITABLE FOR THE TREATMENT OF CNS DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-03-08 WO disclosed